Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana.
Identifieur interne : 001177 ( Main/Exploration ); précédent : 001176; suivant : 001178Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana.
Auteurs : J A Brandful [Ghana] ; F A Apeagyei ; W K Ampofo ; Y. Adu-Sarkodie ; J E Ansah ; V. Nuvor ; S. Aidoo ; K. Ishikawa ; T. Sata ; N. Yamamoto ; S. YamazakiSource :
- Viral immunology [ 0882-8245 ] ; 1999.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Femelle, Ghana (épidémiologie), Humains, Infections opportunistes liées au SIDA (immunologie), Infections opportunistes liées au SIDA (physiopathologie), Infections opportunistes liées au SIDA (épidémiologie), Informatique mathématique, Maladies sexuellement transmissibles (immunologie), Maladies sexuellement transmissibles (physiopathologie), Maladies sexuellement transmissibles (épidémiologie), Mâle, Numération des lymphocytes CD4, Prévalence, Séropositivité VIH (), Séropositivité VIH (immunologie), Séropositivité VIH (physiopathologie), VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- MESH :
- immunologie : Infections opportunistes liées au SIDA, Maladies sexuellement transmissibles, Séropositivité VIH.
- physiopathologie : Infections opportunistes liées au SIDA, Maladies sexuellement transmissibles, Séropositivité VIH.
- épidémiologie : Ghana, Infections opportunistes liées au SIDA, Maladies sexuellement transmissibles.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Informatique mathématique, Mâle, Numération des lymphocytes CD4, Prévalence, Séropositivité VIH, VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- AIDS-Related Opportunistic Infections (epidemiology), AIDS-Related Opportunistic Infections (immunology), AIDS-Related Opportunistic Infections (physiopathology), Adult, CD4 Lymphocyte Count, Female, Ghana (epidemiology), HIV Seropositivity (complications), HIV Seropositivity (immunology), HIV Seropositivity (physiopathology), HIV-1, Humans, Male, Mathematical Computing, Middle Aged, Prevalence, Sexually Transmitted Diseases (epidemiology), Sexually Transmitted Diseases (immunology), Sexually Transmitted Diseases (physiopathology).
- MESH :
- geographic , epidemiology : Ghana.
- complications : HIV Seropositivity.
- epidemiology : AIDS-Related Opportunistic Infections, Sexually Transmitted Diseases.
- immunology : AIDS-Related Opportunistic Infections, HIV Seropositivity, Sexually Transmitted Diseases.
- physiopathology : AIDS-Related Opportunistic Infections, HIV Seropositivity, Sexually Transmitted Diseases.
- Adult, CD4 Lymphocyte Count, Female, HIV-1, Humans, Male, Mathematical Computing, Middle Aged, Prevalence.
Abstract
In view of the strong association between the acquired immunodeficiency syndrome (AIDS) and sexually transmitted diseases (STDs), we screened 182 human immunodeficiency virus (HIV)-1 infected patients over a 15-month period for serological markers to previously encountered or current STDs, most of viral etiology. The relationship between their immunological and clinical status and the prevalence of STDs was assessed and compared with that of 88 HIV-seronegative patients. Hepatitis B virus and Treponema pallidum were the most frequently occurring pathogens in both HIV-1-infected and HIV-seronegative patients. Hepatitis C virus (HCV) infection was also observed in both groups, but no HIV-seronegative patient was infected with human T-lymphotropic virus type 1 (HTLV-1). The Centers for Disease Control clinical staging of A1 through C3, representing asymptomatic to severe AIDS conditions, was observed in HIV-1 patients with or without STDs. A mean CD4 count of 288 cells per microliter (95% CI of 237-340 cells per microliter) in HIV-1 patients was significantly lower (P < 0.05) than that in HIV-seronegative individuals with 1019 cells per microliter (95% CI of 924-1115 cells per microliter), irrespective of whether subjects in either group had previous or current STDs. The mean CD4 count of patients with a single infection from HIV-1 was not significantly different (P = 0.36) from that of HIV-1 patients with multiple infections. HIV-1 infection alone appears to be responsible for the marked immunodeficiency status of seropositive patients observed in this study.
DOI: 10.1089/vim.1999.12.131
PubMed: 10413359
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000231
- to stream PubMed, to step Curation: 000231
- to stream PubMed, to step Checkpoint: 000231
- to stream Ncbi, to step Merge: 000007
- to stream Ncbi, to step Curation: 000007
- to stream Ncbi, to step Checkpoint: 000007
- to stream Main, to step Merge: 001265
- to stream Main, to step Curation: 001177
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana.</title><author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name><affiliation wicri:level="4"><nlm:affiliation>Virology Unit, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Legon.</nlm:affiliation><orgName type="university">Université du Ghana</orgName><country>Ghana</country><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Apeagyei, F A" sort="Apeagyei, F A" uniqKey="Apeagyei F" first="F A" last="Apeagyei">F A Apeagyei</name></author><author><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W K" last="Ampofo">W K Ampofo</name></author><author><name sortKey="Adu Sarkodie, Y" sort="Adu Sarkodie, Y" uniqKey="Adu Sarkodie Y" first="Y" last="Adu-Sarkodie">Y. Adu-Sarkodie</name></author><author><name sortKey="Ansah, J E" sort="Ansah, J E" uniqKey="Ansah J" first="J E" last="Ansah">J E Ansah</name></author><author><name sortKey="Nuvor, V" sort="Nuvor, V" uniqKey="Nuvor V" first="V" last="Nuvor">V. Nuvor</name></author><author><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S" last="Aidoo">S. Aidoo</name></author><author><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K" last="Ishikawa">K. Ishikawa</name></author><author><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T" last="Sata">T. Sata</name></author><author><name sortKey="Yamamoto, N" sort="Yamamoto, N" uniqKey="Yamamoto N" first="N" last="Yamamoto">N. Yamamoto</name></author><author><name sortKey="Yamazaki, S" sort="Yamazaki, S" uniqKey="Yamazaki S" first="S" last="Yamazaki">S. Yamazaki</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1999">1999</date><idno type="RBID">pubmed:10413359</idno><idno type="pmid">10413359</idno><idno type="doi">10.1089/vim.1999.12.131</idno><idno type="wicri:Area/PubMed/Corpus">000231</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000231</idno><idno type="wicri:Area/PubMed/Curation">000231</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000231</idno><idno type="wicri:Area/PubMed/Checkpoint">000231</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000231</idno><idno type="wicri:Area/Ncbi/Merge">000007</idno><idno type="wicri:Area/Ncbi/Curation">000007</idno><idno type="wicri:Area/Ncbi/Checkpoint">000007</idno><idno type="wicri:doubleKey">0882-8245:1999:Brandful J:relationship:between:immunoclinical</idno><idno type="wicri:Area/Main/Merge">001265</idno><idno type="wicri:Area/Main/Curation">001177</idno><idno type="wicri:Area/Main/Exploration">001177</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana.</title><author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name><affiliation wicri:level="4"><nlm:affiliation>Virology Unit, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Legon.</nlm:affiliation><orgName type="university">Université du Ghana</orgName><country>Ghana</country><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Apeagyei, F A" sort="Apeagyei, F A" uniqKey="Apeagyei F" first="F A" last="Apeagyei">F A Apeagyei</name></author><author><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W K" last="Ampofo">W K Ampofo</name></author><author><name sortKey="Adu Sarkodie, Y" sort="Adu Sarkodie, Y" uniqKey="Adu Sarkodie Y" first="Y" last="Adu-Sarkodie">Y. Adu-Sarkodie</name></author><author><name sortKey="Ansah, J E" sort="Ansah, J E" uniqKey="Ansah J" first="J E" last="Ansah">J E Ansah</name></author><author><name sortKey="Nuvor, V" sort="Nuvor, V" uniqKey="Nuvor V" first="V" last="Nuvor">V. Nuvor</name></author><author><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S" last="Aidoo">S. Aidoo</name></author><author><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K" last="Ishikawa">K. Ishikawa</name></author><author><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T" last="Sata">T. Sata</name></author><author><name sortKey="Yamamoto, N" sort="Yamamoto, N" uniqKey="Yamamoto N" first="N" last="Yamamoto">N. Yamamoto</name></author><author><name sortKey="Yamazaki, S" sort="Yamazaki, S" uniqKey="Yamazaki S" first="S" last="Yamazaki">S. Yamazaki</name></author></analytic><series><title level="j">Viral immunology</title><idno type="ISSN">0882-8245</idno><imprint><date when="1999" type="published">1999</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Opportunistic Infections (epidemiology)</term><term>AIDS-Related Opportunistic Infections (immunology)</term><term>AIDS-Related Opportunistic Infections (physiopathology)</term><term>Adult</term><term>CD4 Lymphocyte Count</term><term>Female</term><term>Ghana (epidemiology)</term><term>HIV Seropositivity (complications)</term><term>HIV Seropositivity (immunology)</term><term>HIV Seropositivity (physiopathology)</term><term>HIV-1</term><term>Humans</term><term>Male</term><term>Mathematical Computing</term><term>Middle Aged</term><term>Prevalence</term><term>Sexually Transmitted Diseases (epidemiology)</term><term>Sexually Transmitted Diseases (immunology)</term><term>Sexually Transmitted Diseases (physiopathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Infections opportunistes liées au SIDA (immunologie)</term><term>Infections opportunistes liées au SIDA (physiopathologie)</term><term>Infections opportunistes liées au SIDA (épidémiologie)</term><term>Informatique mathématique</term><term>Maladies sexuellement transmissibles (immunologie)</term><term>Maladies sexuellement transmissibles (physiopathologie)</term><term>Maladies sexuellement transmissibles (épidémiologie)</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Prévalence</term><term>Séropositivité VIH ()</term><term>Séropositivité VIH (immunologie)</term><term>Séropositivité VIH (physiopathologie)</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Seropositivity</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Sexually Transmitted Diseases</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term><term>Maladies sexuellement transmissibles</term><term>Séropositivité VIH</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>HIV Seropositivity</term><term>Sexually Transmitted Diseases</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term><term>Maladies sexuellement transmissibles</term><term>Séropositivité VIH</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>HIV Seropositivity</term><term>Sexually Transmitted Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Infections opportunistes liées au SIDA</term><term>Maladies sexuellement transmissibles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>CD4 Lymphocyte Count</term><term>Female</term><term>HIV-1</term><term>Humans</term><term>Male</term><term>Mathematical Computing</term><term>Middle Aged</term><term>Prevalence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Informatique mathématique</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Prévalence</term><term>Séropositivité VIH</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In view of the strong association between the acquired immunodeficiency syndrome (AIDS) and sexually transmitted diseases (STDs), we screened 182 human immunodeficiency virus (HIV)-1 infected patients over a 15-month period for serological markers to previously encountered or current STDs, most of viral etiology. The relationship between their immunological and clinical status and the prevalence of STDs was assessed and compared with that of 88 HIV-seronegative patients. Hepatitis B virus and Treponema pallidum were the most frequently occurring pathogens in both HIV-1-infected and HIV-seronegative patients. Hepatitis C virus (HCV) infection was also observed in both groups, but no HIV-seronegative patient was infected with human T-lymphotropic virus type 1 (HTLV-1). The Centers for Disease Control clinical staging of A1 through C3, representing asymptomatic to severe AIDS conditions, was observed in HIV-1 patients with or without STDs. A mean CD4 count of 288 cells per microliter (95% CI of 237-340 cells per microliter) in HIV-1 patients was significantly lower (P < 0.05) than that in HIV-seronegative individuals with 1019 cells per microliter (95% CI of 924-1115 cells per microliter), irrespective of whether subjects in either group had previous or current STDs. The mean CD4 count of patients with a single infection from HIV-1 was not significantly different (P = 0.36) from that of HIV-1 patients with multiple infections. HIV-1 infection alone appears to be responsible for the marked immunodeficiency status of seropositive patients observed in this study.</div></front></TEI><affiliations><list><country><li>Ghana</li></country><region><li>Région du Grand Accra</li></region><settlement><li>Accra</li><li>Legon (Ghana)</li></settlement><orgName><li>Université du Ghana</li></orgName></list><tree><noCountry><name sortKey="Adu Sarkodie, Y" sort="Adu Sarkodie, Y" uniqKey="Adu Sarkodie Y" first="Y" last="Adu-Sarkodie">Y. Adu-Sarkodie</name><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S" last="Aidoo">S. Aidoo</name><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W K" last="Ampofo">W K Ampofo</name><name sortKey="Ansah, J E" sort="Ansah, J E" uniqKey="Ansah J" first="J E" last="Ansah">J E Ansah</name><name sortKey="Apeagyei, F A" sort="Apeagyei, F A" uniqKey="Apeagyei F" first="F A" last="Apeagyei">F A Apeagyei</name><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K" last="Ishikawa">K. Ishikawa</name><name sortKey="Nuvor, V" sort="Nuvor, V" uniqKey="Nuvor V" first="V" last="Nuvor">V. Nuvor</name><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T" last="Sata">T. Sata</name><name sortKey="Yamamoto, N" sort="Yamamoto, N" uniqKey="Yamamoto N" first="N" last="Yamamoto">N. Yamamoto</name><name sortKey="Yamazaki, S" sort="Yamazaki, S" uniqKey="Yamazaki S" first="S" last="Yamazaki">S. Yamazaki</name></noCountry><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001177 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001177 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:10413359
|texte= Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:10413359" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |